Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01763567 · ClinicalTrials.gov registry record
Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)
A clinical trial, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- 19
- Enrollment target
NCT01763567: Completed study, sponsored by Medtronic MiniMed.
NCT01763567 is a clinical trial that has completed, run by Medtronic MiniMed. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01763567 has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.
Primary Outcome
Mean Absolute Relative Difference (MARD), calculated as the absolute difference of \[(sensor glucose values - iSTAT glucose values) / iSTAT glucose values\]. The portable i-STAT handheld makes patient-side testing easy: * Requires no special sample preparation or user calibration; maintenance is minimal * Weighs 18 ounces, making it portable * Patient-side testing is as easy as entering the operator and patient information into the handheld, inserting one of the several filled test cartridges,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-09 |
What the finished NCT01763567 record still lists
NCT01763567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01763567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01763567 about?
NCT01763567 is a clinical study titled "Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)". The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.
What is the current status of trial NCT01763567?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2012-03. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01763567?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia